Poly Medicure Limited v. Assistant Controller Of Patents And Designs

Every founder dreams of turning a breakthrough idea into a protected asset — but what happens when the patent office says your invention doesn't even qualify as an invention? For Poly Medicure Limited, a player in the medical devices space, this question became a courtroom reality. Their patent application was rejected on the grounds that it failed to meet the threshold of Section 2(1)(j) of the Patents Act, 1970 — the very definition of what counts as a patentable invention. This case is a stark reminder that the journey from innovation to granted patent is rarely straightforward, and that understanding the legal definition of an invention is non-negotiable for any serious IP strategy.

Poly Medicure Limited, a company operating in the medical devices sector, filed a patent application numbered 2109/DEL/2011 before the Indian Patent Office. The application was examined by the Assistant Controller of Patents and Designs, who ultimately rejected it. The ground for rejection was that the subject matter claimed in the application did not satisfy the requirements of Section 2(1)(j) of the Patents Act, 1970 — the statutory provision that defines what constitutes an "invention" eligible for patent protection in India. Dissatisfied with this rejection, Poly Medicure Limited escalated the matter by way of an appeal before the High Court, seeking relief from the decision of the Assistant Controller.

At the heart of the dispute was a fundamental question: did the subject matter of Poly Medicure's application truly meet the legal definition of an "invention" under Indian patent law? The Assistant Controller of Patents and Designs had concluded that it did not, applying the criteria laid down under Section 2(1)(j) of the Patents Act, 1970. Poly Medicure Limited, on the other hand, pushed back against this finding, arguing that its application deserved a closer and more substantive examination. The legal friction centered on the interpretation and application of patentability criteria — a battleground where technical innovation meets statutory language, and where the outcome can make or break a company's IP portfolio.

The High Court did not deliver a final ruling on the merits of the patent application. Instead, it took a procedural yet significant step: it granted certain exemptions to Poly Medicure Limited in the course of the proceedings and directed that further hearings be conducted. Crucially, the court ordered that the Assistant Controller be present during these further proceedings, signaling the importance it placed on a thorough and properly conducted examination. The court reserved its judgment, leaving the ultimate question of patentability to be determined after the directed hearings take place. The matter thus remains pending, with the next phase focused squarely on whether the application satisfies the invention criteria under the Patents Act, 1970.

For founders and IP professionals, this case underscores a critical lesson: the definition of an "invention" under Section 2(1)(j) is the first gate every patent application must pass through, and failing at this stage can halt the entire process before substantive examination even begins. When facing a rejection on patentability grounds, pursuing appellate remedies and seeking procedural fairness — such as ensuring the examining authority is present and heard — can be a strategic move. More broadly, innovators should invest time upfront in drafting claims that clearly articulate novelty, inventive step, and industrial application, so that their applications withstand the scrutiny of the patent office from day one.